APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Milk Oligosaccharides (HMO)

Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycan’s that are found in and unique to human breast milk, despite not actually being digestible by human infants. HMOs function as a prebiotic helping to establish commensal bacteria. HMOs also function as anti-adhesives that help prevent the attachment of microbial pathogens to mucosal surfaces. Human milk oligosaccharides are manufactured through numerous processes which involve the use of several chemicals, enzymes or microbes. The technology used for manufacturing of human milk oligosaccharides is very complex and expensive, thus restricting their large-scale production. Major players have been increasing investing increasingly on R&D for low-cost production and the introduction of effective technologies for product synthesis.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycan’s that are found in and unique to human breast milk, despite not actually being digestible by human infants. HMOs function as a prebiotic helping to establish commensal bacteria. HMOs also function as anti-adhesives that help prevent the attachment of microbial pathogens to mucosal surfaces. Human milk oligosaccharides are manufactured through numerous processes which involve the use of several chemicals, enzymes or microbes. The technology used for manufacturing of human milk oligosaccharides is very complex and expensive, thus restricting their large-scale production. Major players have been increasing investing increasingly on R&D for low-cost production and the introduction of effective technologies for product synthesis.

Selected research

Market Structure

Global Human Milk Oligosaccharides (HMO) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

9 January 2026182 pages

Choose your research edition.

Industry ResearchHuman Milk Oligosaccharides (HMO) Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Milk Oligosaccharides (HMO) Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Human Milk Oligosaccharides (HMO) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Milk Oligosaccharides (HMO) Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Milk Oligosaccharides (HMO) Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycan’s that are found in and unique to human breast milk, despite not actually being digestible by human infants. HMOs function as a prebiotic helping to establish commensal bacteria. HMOs also function as anti-adhesives that help prevent the attachment of microbial pathogens to mucosal surfaces. Human milk oligosaccharides are manufactured through numerous processes which involve the use of several chemicals, enzymes or microbes. The technology used for manufacturing of human milk oligosaccharides is very complex and expensive, thus restricting their large-scale production. Major players have been increasing investing increasingly on R&D for low-cost production and the introduction of effective technologies for product synthesis.

Global core Human Milk Oligosaccharides (HMO) manufacturers include Abbott, Glycom etc.The top 2 companies hold a share about 70%.North America is the largest market, with a share about 50%, followed by Europe and Asia Pacific with the share about 34% and 14%.

This report provides an overview of the global Human Milk Oligosaccharides (HMO) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Human Milk Oligosaccharides (HMO) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Human Milk Oligosaccharides (HMO) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Human Milk Oligosaccharides (HMO) market size, projected growth trends, production technologies, key applications, and end-use industries.

Human Milk Oligosaccharides (HMO) Segment by Company

Abbott

Inbiose

Glycom

Chr. Hansen (Jennewein)

Elicityl SA

ZuChem

Dextra Laboratories

Human Milk Oligosaccharides (HMO) Segment by Type

2'-FL & 3-FL

Sialyllactose

LNT & LNnT

Human Milk Oligosaccharides (HMO) Segment by Application

Infant Formula

Functional Food & Beverages

Food/Medical Supplements

Others

Human Milk Oligosaccharides (HMO) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Milk Oligosaccharides (HMO) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Milk Oligosaccharides (HMO) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Milk Oligosaccharides (HMO).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Human Milk Oligosaccharides (HMO) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Human Milk Oligosaccharides (HMO) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Human Milk Oligosaccharides (HMO) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Human Milk Oligosaccharides (HMO) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Human Milk Oligosaccharides (HMO) Industry Trends Table 2. Human Milk Oligosaccharides (HMO) Industry Drivers Table 3. Human Milk Oligosaccharides (HMO) Industry Opportunities and Challenges Table 4. Human Milk Oligosaccharides (HMO) Industry Restraints Table 5. Global Human Milk Oligosaccharides (HMO) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Human Milk Oligosaccharides (HMO) Sales by Manufacturers (Tons) & (2021-2026) Table 8. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Manufacturers Table 9. Global Human Milk Oligosaccharides (HMO) Average Sales Price (USD/Ton) of Manufacturers (2021-2026) Table 10. Global Human Milk Oligosaccharides (HMO) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Human Milk Oligosaccharides (HMO) Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Human Milk Oligosaccharides (HMO) Manufacturers, Product Type & Application Table 13. Global Human Milk Oligosaccharides (HMO) Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Human Milk Oligosaccharides (HMO) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 2'-FL & 3-FL Table 17. Major Manufacturers of Sialyllactose Table 18. Major Manufacturers of LNT & LNnT Table 19. Global Human Milk Oligosaccharides (HMO) Sales by Type 2021 VS 2025 VS 2032 (Tons) Table 20. Global Human Milk Oligosaccharides (HMO) Sales by Type (2021-2026) & (Tons) Table 21. Global Human Milk Oligosaccharides (HMO) Sales by Type (2027-2032) & (Tons) Table 22. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2021-2026) Table 23. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2027-2032) Table 24. Global Human Milk Oligosaccharides (HMO) Revenue by Type 2021 VS 2025 VS 2032 (Tons) Table 25. Global Human Milk Oligosaccharides (HMO) Revenue by Type (2021-2026) & (Tons) Table 26. Global Human Milk Oligosaccharides (HMO) Revenue by Type (2027-2032) & (Tons) Table 27. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2021-2026) Table 28. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Infant Formula Table 30. Major Manufacturers of Functional Food & Beverages Table 31. Major Manufacturers of Food/Medical Supplements Table 32. Major Manufacturers of Others Table 33. Global Human Milk Oligosaccharides (HMO) Sales by Application 2021 VS 2025 VS 2032 (Tons) Table 34. Global Human Milk Oligosaccharides (HMO) Sales by Application (2021-2026) & (Tons) Table 35. Global Human Milk Oligosaccharides (HMO) Sales by Application (2027-2032) & (Tons) Table 36. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2021-2026) Table 37. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2027-2032) Table 38. Global Human Milk Oligosaccharides (HMO) Revenue by Application 2021 VS 2025 VS 2032 (Tons) Table 39. Global Human Milk Oligosaccharides (HMO) Revenue by Application (2021-2026) & (Tons) Table 40. Global Human Milk Oligosaccharides (HMO) Revenue by Application (2027-2032) & (Tons) Table 41. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Application (2021-2026) Table 42. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Application (2027-2032) Table 43. Global Human Milk Oligosaccharides (HMO) Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 44. Global Human Milk Oligosaccharides (HMO) Sales by Region (2021-2026) & (Tons) Table 45. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Region (2021-2026) Table 46. Global Human Milk Oligosaccharides (HMO) Sales Forecasted by Region (2027-2032) & (Tons) Table 47. Global Human Milk Oligosaccharides (HMO) Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Human Milk Oligosaccharides (HMO) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 49. North America Human Milk Oligosaccharides (HMO) Sales by Country (2021-2026) & (Tons) Table 50. North America Human Milk Oligosaccharides (HMO) Sales by Country (2027-2032) & (Tons) Table 51. Europe Human Milk Oligosaccharides (HMO) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 52. Europe Human Milk Oligosaccharides (HMO) Sales by Country (2021-2026) & (Tons) Table 53. Europe Human Milk Oligosaccharides (HMO) Sales by Country (2027-2032) & (Tons) Table 54. Asia Pacific Human Milk Oligosaccharides (HMO) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 55. Asia Pacific Human Milk Oligosaccharides (HMO) Sales by Country (2021-2026) & (Tons) Table 56. Asia Pacific Human Milk Oligosaccharides (HMO) Sales by Country (2027-2032) & (Tons) Table 57. South America, Middle East and Africa Human Milk Oligosaccharides (HMO) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 58. South America, Middle East and Africa Human Milk Oligosaccharides (HMO) Sales by Country (2021-2026) & (Tons) Table 59. South America, Middle East and Africa Human Milk Oligosaccharides (HMO) Sales by Country (2027-2032) & (Tons) Table 60. Global Human Milk Oligosaccharides (HMO) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Human Milk Oligosaccharides (HMO) Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Human Milk Oligosaccharides (HMO) Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Region (2021-2026) Table 64. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Region (2027-2032) Table 65. Abbott Company Information Table 66. Abbott Business Overview Table 67. Abbott Human Milk Oligosaccharides (HMO) Sales (Tons), Price (USD/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Abbott Human Milk Oligosaccharides (HMO) Product Portfolio Table 69. Abbott Recent Development Table 70. Inbiose Company Information Table 71. Inbiose Business Overview Table 72. Inbiose Human Milk Oligosaccharides (HMO) Sales (Tons), Price (USD/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Inbiose Human Milk Oligosaccharides (HMO) Product Portfolio Table 74. Inbiose Recent Development Table 75. Glycom Company Information Table 76. Glycom Business Overview Table 77. Glycom Human Milk Oligosaccharides (HMO) Sales (Tons), Price (USD/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Glycom Human Milk Oligosaccharides (HMO) Product Portfolio Table 79. Glycom Recent Development Table 80. Chr. Hansen (Jennewein) Company Information Table 81. Chr. Hansen (Jennewein) Business Overview Table 82. Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Sales (Tons), Price (USD/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Product Portfolio Table 84. Chr. Hansen (Jennewein) Recent Development Table 85. Elicityl SA Company Information Table 86. Elicityl SA Business Overview Table 87. Elicityl SA Human Milk Oligosaccharides (HMO) Sales (Tons), Price (USD/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Elicityl SA Human Milk Oligosaccharides (HMO) Product Portfolio Table 89. Elicityl SA Recent Development Table 90. ZuChem Company Information Table 91. ZuChem Business Overview Table 92. ZuChem Human Milk Oligosaccharides (HMO) Sales (Tons), Price (USD/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. ZuChem Human Milk Oligosaccharides (HMO) Product Portfolio Table 94. ZuChem Recent Development Table 95. Dextra Laboratories Company Information Table 96. Dextra Laboratories Business Overview Table 97. Dextra Laboratories Human Milk Oligosaccharides (HMO) Sales (Tons), Price (USD/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Dextra Laboratories Human Milk Oligosaccharides (HMO) Product Portfolio Table 99. Dextra Laboratories Recent Development Table 100. Key Raw Materials Table 101. Raw Materials Key Suppliers Table 102. Human Milk Oligosaccharides (HMO) Distributors List Table 103. Human Milk Oligosaccharides (HMO) Customers List Table 104. Research Programs/Design for This Report Table 105. Authors List of This Report Table 106. Secondary Sources Table 107. Primary Sources List of Figures Figure 1. Human Milk Oligosaccharides (HMO) Product Image Figure 2. Global Human Milk Oligosaccharides (HMO) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Milk Oligosaccharides (HMO) Market Size (2021-2032) & (US$ Million) Figure 4. Global Human Milk Oligosaccharides (HMO) Sales (2021-2032) & (Tons) Figure 5. Global Human Milk Oligosaccharides (HMO) Average Price (USD/Ton) & (2021-2032) Figure 6. Global Top 5 and 10 Human Milk Oligosaccharides (HMO) Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 2'-FL & 3-FL Image Figure 9. Sialyllactose Image Figure 10. LNT & LNnT Image Figure 11. Global Human Milk Oligosaccharides (HMO) Sales by Type (2021 VS 2025 VS 2032) & (Tons) Figure 12. Global Human Milk Oligosaccharides (HMO) Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2021-2032) Figure 14. Global Human Milk Oligosaccharides (HMO) Revenue by Type (2021 VS 2025 VS 2032) & (Tons) Figure 15. Global Human Milk Oligosaccharides (HMO) Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2021-2032) Figure 17. Infant Formula Image Figure 18. Functional Food & Beverages Image Figure 19. Food/Medical Supplements Image Figure 20. Others Image Figure 21. Global Human Milk Oligosaccharides (HMO) Sales by Application (2021 VS 2025 VS 2032) & (Tons) Figure 22. Global Human Milk Oligosaccharides (HMO) Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2021-2032) Figure 24. Global Human Milk Oligosaccharides (HMO) Revenue by Application (2021 VS 2025 VS 2032) & (Tons) Figure 25. Global Human Milk Oligosaccharides (HMO) Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Application (2021-2032) Figure 27. North America Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2021-2032) & (Tons) Figure 28. North America Human Milk Oligosaccharides (HMO) Sales Market Share by Country (2021-2032) Figure 29. U.S. Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2021-2032) & (Tons) Figure 30. Canada Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2021-2032) & (Tons) Figure 31. Mexico Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2021-2032) & (Tons) Figure 32. Europe Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2021-2032) & (Tons) Figure 33. Europe Human Milk Oligosaccharides (HMO) Sales Market Share by Country (2021-2032) Figure 34. Germany Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2021-2032) & (Tons) Figure 35. France Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2021-2032) & (Tons) Figure 36. U.K. Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2021-2032) & (Tons) Figure 37. Italy Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2021-2032) & (Tons) Figure 38. Netherlands Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2021-2032) & (Tons) Figure 39. Asia Pacific Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2021-2032) & (Tons) Figure 40. Asia Pacific Human Milk Oligosaccharides (HMO) Sales Market Share by Country (2021-2032) Figure 41. China Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2021-2032) & (Tons) Figure 42. Japan Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2021-2032) & (Tons) Figure 43. South Korea Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2021-2032) & (Tons) Figure 44. Southeast Asia Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2021-2032) & (Tons) Figure 45. India Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2021-2032) & (Tons) Figure 46. Australia Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2021-2032) & (Tons) Figure 47. South America, Middle East and Africa Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2021-2032) & (Tons) Figure 48. South America, Middle East and Africa Human Milk Oligosaccharides (HMO) Sales Market Share by Country (2021-2032) Figure 49. Brazil Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2021-2032) & (Tons) Figure 50. South Africa Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2021-2032) & (Tons) Figure 51. Saudi Arabia Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2021-2032) & (Tons) Figure 52. Turkey Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2021-2032) & (Tons) Figure 53. Argentina Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2021-2032) & (Tons) Figure 54. UAE Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2021-2032) & (Tons) Figure 55. Egypt Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2021-2032) & (Tons) Figure 56. Chile Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2021-2032) & (Tons) Figure 57. Global Human Milk Oligosaccharides (HMO) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Human Milk Oligosaccharides (HMO) Revenue (2021-2032) & (US$ Million) Figure 60. North America Human Milk Oligosaccharides (HMO) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Human Milk Oligosaccharides (HMO) Revenue (2021-2032) & (US$ Million) Figure 62. Europe Human Milk Oligosaccharides (HMO) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Human Milk Oligosaccharides (HMO) Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Human Milk Oligosaccharides (HMO) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Human Milk Oligosaccharides (HMO) Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Human Milk Oligosaccharides (HMO) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Human Milk Oligosaccharides (HMO) Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Human Milk Oligosaccharides (HMO) Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 2'-FL & 3-FL
  • Sialyllactose
  • LNT & LNnT
Applications
  • Infant Formula
  • Functional Food & Beverages
  • Food/Medical Supplements
  • Others
Companies covered
  • Abbott
  • Inbiose
  • Glycom
  • Chr. Hansen (Jennewein)
  • Elicityl SA
  • ZuChem
  • Dextra Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Human Milk Oligosaccharides (HMO) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Human Milk Oligosaccharides (HMO) Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Human Milk Oligosaccharides (HMO) Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Human Milk Oligosaccharides (HMO) Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Human Milk Oligosaccharides (HMO) Market Dynamics
  1. 2.1 Human Milk Oligosaccharides (HMO) Industry Trends
  2. 2.2 Human Milk Oligosaccharides (HMO) Industry Drivers
  3. 2.3 Human Milk Oligosaccharides (HMO) Industry Opportunities and Challenges
  4. 2.4 Human Milk Oligosaccharides (HMO) Industry Restraints
3 Human Milk Oligosaccharides (HMO) Market by Manufacturers
  1. 3.1 Global Human Milk Oligosaccharides (HMO) Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Human Milk Oligosaccharides (HMO) Sales by Manufacturers (2021-2026)
  3. 3.3 Global Human Milk Oligosaccharides (HMO) Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Human Milk Oligosaccharides (HMO) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Human Milk Oligosaccharides (HMO) Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Human Milk Oligosaccharides (HMO) Manufacturers, Product Type & Application
  7. 3.7 Global Human Milk Oligosaccharides (HMO) Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Human Milk Oligosaccharides (HMO) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Human Milk Oligosaccharides (HMO) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Human Milk Oligosaccharides (HMO) Tier 1, Tier 2, and Tier 3
4 Human Milk Oligosaccharides (HMO) Market by Type
  1. 4.1 Human Milk Oligosaccharides (HMO) Type Introduction
  2. 4.1.1 2'-FL & 3-FL
  3. 4.1.2 Sialyllactose
  4. 4.1.3 LNT & LNnT
  5. 4.2 Global Human Milk Oligosaccharides (HMO) Sales by Type
  6. 4.2.1 Global Human Milk Oligosaccharides (HMO) Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Human Milk Oligosaccharides (HMO) Sales by Type (2021-2032)
  8. 4.2.3 Global Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2021-2032)
  9. 4.3 Global Human Milk Oligosaccharides (HMO) Revenue by Type
  10. 4.3.1 Global Human Milk Oligosaccharides (HMO) Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Human Milk Oligosaccharides (HMO) Revenue by Type (2021-2032)
  12. 4.3.3 Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2021-2032)
5 Human Milk Oligosaccharides (HMO) Market by Application
  1. 5.1 Human Milk Oligosaccharides (HMO) Application Introduction
  2. 5.1.1 Infant Formula
  3. 5.1.2 Functional Food & Beverages
  4. 5.1.3 Food/Medical Supplements
  5. 5.1.4 Others
  6. 5.2 Global Human Milk Oligosaccharides (HMO) Sales by Application
  7. 5.2.1 Global Human Milk Oligosaccharides (HMO) Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Human Milk Oligosaccharides (HMO) Sales by Application (2021-2032)
  9. 5.2.3 Global Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2021-2032)
  10. 5.3 Global Human Milk Oligosaccharides (HMO) Revenue by Application
  11. 5.3.1 Global Human Milk Oligosaccharides (HMO) Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Human Milk Oligosaccharides (HMO) Revenue by Application (2021-2032)
  13. 5.3.3 Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Application (2021-2032)
6 Global Human Milk Oligosaccharides (HMO) Sales by Region
  1. 6.1 Global Human Milk Oligosaccharides (HMO) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Human Milk Oligosaccharides (HMO) Sales by Region (2021-2032)
  3. 6.2.1 Global Human Milk Oligosaccharides (HMO) Sales by Region (2021-2026)
  4. 6.2.2 Global Human Milk Oligosaccharides (HMO) Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Human Milk Oligosaccharides (HMO) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Human Milk Oligosaccharides (HMO) Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Human Milk Oligosaccharides (HMO) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Human Milk Oligosaccharides (HMO) Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Human Milk Oligosaccharides (HMO) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Human Milk Oligosaccharides (HMO) Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Human Milk Oligosaccharides (HMO) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Human Milk Oligosaccharides (HMO) Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Human Milk Oligosaccharides (HMO) Revenue by Region
  1. 7.1 Global Human Milk Oligosaccharides (HMO) Revenue by Region
  2. 7.1.1 Global Human Milk Oligosaccharides (HMO) Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Human Milk Oligosaccharides (HMO) Revenue by Region (2021-2026)
  4. 7.1.3 Global Human Milk Oligosaccharides (HMO) Revenue by Region (2027-2032)
  5. 7.1.4 Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Human Milk Oligosaccharides (HMO) Revenue (2021-2032)
  8. 7.2.2 North America Human Milk Oligosaccharides (HMO) Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Human Milk Oligosaccharides (HMO) Revenue (2021-2032)
  11. 7.3.2 Europe Human Milk Oligosaccharides (HMO) Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Human Milk Oligosaccharides (HMO) Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Human Milk Oligosaccharides (HMO) Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Human Milk Oligosaccharides (HMO) Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Human Milk Oligosaccharides (HMO) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott
  2. 8.1.1 Abbott Company Information
  3. 8.1.2 Abbott Business Overview
  4. 8.1.3 Abbott Human Milk Oligosaccharides (HMO) Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Human Milk Oligosaccharides (HMO) Product Portfolio
  6. 8.1.5 Abbott Recent Developments
  7. 8.2 Inbiose
  8. 8.2.1 Inbiose Company Information
  9. 8.2.2 Inbiose Business Overview
  10. 8.2.3 Inbiose Human Milk Oligosaccharides (HMO) Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Inbiose Human Milk Oligosaccharides (HMO) Product Portfolio
  12. 8.2.5 Inbiose Recent Developments
  13. 8.3 Glycom
  14. 8.3.1 Glycom Company Information
  15. 8.3.2 Glycom Business Overview
  16. 8.3.3 Glycom Human Milk Oligosaccharides (HMO) Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Glycom Human Milk Oligosaccharides (HMO) Product Portfolio
  18. 8.3.5 Glycom Recent Developments
  19. 8.4 Chr. Hansen (Jennewein)
  20. 8.4.1 Chr. Hansen (Jennewein) Company Information
  21. 8.4.2 Chr. Hansen (Jennewein) Business Overview
  22. 8.4.3 Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Product Portfolio
  24. 8.4.5 Chr. Hansen (Jennewein) Recent Developments
  25. 8.5 Elicityl SA
  26. 8.5.1 Elicityl SA Company Information
  27. 8.5.2 Elicityl SA Business Overview
  28. 8.5.3 Elicityl SA Human Milk Oligosaccharides (HMO) Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Elicityl SA Human Milk Oligosaccharides (HMO) Product Portfolio
  30. 8.5.5 Elicityl SA Recent Developments
  31. 8.6 ZuChem
  32. 8.6.1 ZuChem Company Information
  33. 8.6.2 ZuChem Business Overview
  34. 8.6.3 ZuChem Human Milk Oligosaccharides (HMO) Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 ZuChem Human Milk Oligosaccharides (HMO) Product Portfolio
  36. 8.6.5 ZuChem Recent Developments
  37. 8.7 Dextra Laboratories
  38. 8.7.1 Dextra Laboratories Company Information
  39. 8.7.2 Dextra Laboratories Business Overview
  40. 8.7.3 Dextra Laboratories Human Milk Oligosaccharides (HMO) Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Dextra Laboratories Human Milk Oligosaccharides (HMO) Product Portfolio
  42. 8.7.5 Dextra Laboratories Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Human Milk Oligosaccharides (HMO) Value Chain Analysis
  2. 9.1.1 Human Milk Oligosaccharides (HMO) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Human Milk Oligosaccharides (HMO) Production Mode & Process
  6. 9.2 Human Milk Oligosaccharides (HMO) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Human Milk Oligosaccharides (HMO) Distributors
  9. 9.2.3 Human Milk Oligosaccharides (HMO) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst